871507-79-8Relevant articles and documents
New tridentate cyclometalated platinum(II) and palladium(II) complexes of N,2-diphenyl-8-quinolinamine: Syntheses, crystal structures, and photophysical properties
Mao, Lisheng,Moriuchi, Toshiyuki,Sakurai, Hidehiro,Fujii, Hiroyuki,Hirao, Toshikazu
, p. 8419 - 8422 (2005)
A new tridentate cyclometalated platinum(II) complex derived from N,2-diphenyl-8-quinolinamine, which consists of two crystallographic independent molecules with two intermolecular N-H-Cl-Pt hydrogen bonds forming a dimer, exhibited a low-energy luminesce
Iron Complexes of Square Planar Tetradentate Polypyridyl-Type Ligands as Catalysts for Water Oxidation
Wickramasinghe, Lanka D.,Zhou, Rongwei,Zong, Ruifa,Vo, Pascal,Gagnon, Kevin J.,Thummel, Randolph P.
supporting information, p. 13260 - 13263 (2015/11/09)
The tetradentate ligand, 2-(pyrid-2′-yl)-8-(1″,10″-phenanthrolin-2″-yl)-quinoline (ppq) embodies a quaterpyridine backbone but with the quinoline C8 providing an additional sp2 center separating the two bipyridine-like subunits. Thus, the four
IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
-
Page/Page column 29, (2008/12/04)
Compounds of Formula I: in which A, B, R1, R1a, R2, R3, R4, R5 R6, R7 and R8 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by class 3 and class 5 receptor tyrosine kinases. Particular compounds of this invention have also been found to be inhibitors of Pim-1.